Hemispherian Competitors and Similar CompaniesClear all
Hemispherian's competitors and similar companies include Xencor and Splash Pharmaceuticals.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. | |||
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Oslo, NO HQ | Locations Pasadena, US HQ San Diego, US | Locations San Diego, US HQ |
Employees | Employees 10 | Employees 2604% increase | Employees 1 |
Funding | |||
Latest funding round | Latest funding round $ 7.4m (over 3 years ago) | Latest funding round N/A | Latest funding round $ 22.5m (over 17 years ago) |
Total funding raised | Total funding raised $ 9.8m | Total funding raised $ 108.4m | Total funding raised $ 23m |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View company
Splash Pharmaceuticals
HQ
San Diego, US
Employees
1
Splash Pharmaceuticals is a cancer therapy company.
View company